Detalhe da pesquisa
1.
Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein.
Immunity
; 55(9): 1710-1724.e8, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944529
2.
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages.
Nat Commun
; 14(1): 2249, 2023 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076511
3.
Characteristics and functions of infection-enhancing antibodies to the N-terminal domain of SARS-CoV-2.
bioRxiv
; 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786672
4.
Characterization of SARS-CoV-2 Convalescent Patients' Serological Repertoire Reveals High Prevalence of Iso-RBD Antibodies.
bioRxiv
; 2023 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37745524
5.
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection.
Sci Immunol
; 7(73): eabq3511, 2022 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549299
6.
Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
Science
; 375(6584): 1041-1047, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143256
7.
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies.
Cell Host Microbe
; 30(2): 248-259.e6, 2022 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998466
8.
Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
Sci Transl Med
; 14(636): eabl5399, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294259
9.
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
Sci Immunol
; 6(56)2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622975
10.
A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants.
mBio
; 12(5): e0247321, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607456
11.
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody.
Science
; 371(6531): 823-829, 2021 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33495307
12.
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19.
bioRxiv
; 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236009
13.
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein.
bioRxiv
; 2020 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32511337
14.
Broad neutralization of SARS-related viruses by human monoclonal antibodies.
Science
; 369(6504): 731-736, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32540900
15.
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies
Artigo
em Inglês
| ARCA | ID: arc-57162